DK0910379T3 - Plaster til transdermal påføring af pergolid - Google Patents

Plaster til transdermal påføring af pergolid

Info

Publication number
DK0910379T3
DK0910379T3 DK97933646T DK97933646T DK0910379T3 DK 0910379 T3 DK0910379 T3 DK 0910379T3 DK 97933646 T DK97933646 T DK 97933646T DK 97933646 T DK97933646 T DK 97933646T DK 0910379 T3 DK0910379 T3 DK 0910379T3
Authority
DK
Denmark
Prior art keywords
pergolide
patch
transdermal application
transdermal
application
Prior art date
Application number
DK97933646T
Other languages
English (en)
Inventor
Wilfried Fischer
Anna Sendl-Lang
Dagmar Zeh-Herwerth
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Application granted granted Critical
Publication of DK0910379T3 publication Critical patent/DK0910379T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97933646T 1996-07-02 1997-07-02 Plaster til transdermal påføring af pergolid DK0910379T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19626621A DE19626621A1 (de) 1996-07-02 1996-07-02 Pflaster zur transdermalen Anwendung von Pergolid
PCT/EP1997/003458 WO1998000142A1 (de) 1996-07-02 1997-07-02 Pflaster zur transdermalen anwendung von pergolid

Publications (1)

Publication Number Publication Date
DK0910379T3 true DK0910379T3 (da) 2003-08-11

Family

ID=7798713

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97933646T DK0910379T3 (da) 1996-07-02 1997-07-02 Plaster til transdermal påføring af pergolid

Country Status (7)

Country Link
EP (1) EP0910379B1 (da)
JP (1) JP2000514053A (da)
AT (1) ATE238054T1 (da)
DE (2) DE19626621A1 (da)
DK (1) DK0910379T3 (da)
ES (1) ES2198584T3 (da)
WO (1) WO1998000142A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6193993B1 (en) 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
DE19820151A1 (de) * 1998-05-06 1999-11-11 Hexal Ag Transdermales therapeutisches System zur Anwendung von Candesartan
DE19821788C1 (de) * 1998-05-15 1999-12-02 Sanol Arznei Schwarz Gmbh Transdermales Therapeutisches System (TTS) Pergolid enthaltend
DE19855704C2 (de) 1998-12-03 2002-08-01 Lothar Saiger Verwendung einer Wirkstoffkombination zur Behandlung der Parkinsonschen Krankheit
EP1685838A1 (en) * 2000-08-16 2006-08-02 Pharmacia & Upjohn Company LLC Compounds for the treatment of addictive disorders
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10341317B4 (de) * 2003-09-03 2008-10-23 Axxonis Pharma Ag Transdermales therapeutisches System (TTS) zur Verabreichung von Ergolinverbindungen ausgenommen Pergolid
DE10110953A1 (de) * 2001-03-07 2002-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von partiellen Dopamin-D2-Agonisten
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
TW200514582A (en) * 2003-10-31 2005-05-01 Hisamitsu Pharmaceutical Co Transdermal preparation and method for reducing side effect in pergolide therapy

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
GR861128B (en) * 1985-05-06 1986-08-26 Sandoz Ag New use of dopamine agonists
DE3814521A1 (de) * 1987-05-07 1988-11-17 Sandoz Ag Neue anwendung von dopaminrezeptor-agonisten
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
US4929640A (en) * 1988-04-04 1990-05-29 George D. McAdory Medicaments intended for combined use in the improvement of lymphocyte function
US5252335A (en) * 1989-07-12 1993-10-12 Cygnus Therapeutic Systems Transdermal administration of lisuride
US5114948A (en) * 1989-10-19 1992-05-19 Eli Lilly And Company Stabilized pergolide compositions
GB9006772D0 (en) * 1990-03-27 1990-05-23 Erba Carlo Spa 4-piperidinyl-ergoline derivatives
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5063234A (en) * 1990-05-25 1991-11-05 Eli Lilly And Company Method of inhibiting demineralization of bone
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
IT1252163B (it) * 1991-12-03 1995-06-05 Poli Ind Chimica Spa Composizioni farmaceutiche per la neuroprotezione nelle malattie neurologiche di carattere degenerativo o su base ischemica
WO1996004910A1 (en) * 1994-08-09 1996-02-22 Hahnemann University Treatment of opiate withdrawal syndrome
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide

Also Published As

Publication number Publication date
DE59709922D1 (de) 2003-05-28
WO1998000142A1 (de) 1998-01-08
ES2198584T3 (es) 2004-02-01
AU727267B2 (en) 2000-12-07
ATE238054T1 (de) 2003-05-15
AU3692697A (en) 1998-01-21
JP2000514053A (ja) 2000-10-24
EP0910379A1 (de) 1999-04-28
DE19626621A1 (de) 1998-01-08
EP0910379B1 (de) 2003-04-23

Similar Documents

Publication Publication Date Title
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
ATE264863T1 (de) 28-epirapaloge
NO980126D0 (no) Plaster-formulering for perkantal administrering av fenantyl
DE69907977D1 (de) Pyrrolobenzodiazepine
DE60041761D1 (de) Tribonektine
DK0833839T3 (da) Heterocykliske peptidylforbindelser, der er nyttige til behandling af thrombinrelaterede sygdomme
DK0842944T3 (da) Heterocycler som inhibitorer af leukocytadhæsionen og som antagonister af VLA-4
DK0799819T3 (da) 1-Dimethylaminomethyl-2-phenylcycloalk-2-enforbindelser med analgesisk virkning
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK0910379T3 (da) Plaster til transdermal påføring af pergolid
ID21763A (id) Perawatan untuk peradangan persendian
SE9601556D0 (sv) New pharmaceutical formulation of a thrombin inhibitor for parenteral use
EE04043B1 (et) H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks
DK1150704T3 (da) Melagatran til behandling af betændelse
DE60017961D1 (de) Erste-Hilfe Klebepflaster
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
NO20000814L (no) Identifikasjon for klebende flateformede dermale og transdermale terapeutiske administrasjonsformer under anvendelse av et klebende plaster som informasjonsbærer, såvel som fremgangsmåte for deres fremstilling
NO20001548L (no) Endotelinantagonist og en renin-angiotensinsystem inhibitor som et kombinert preparat
DE69821096D1 (de) Pflaster-zubereitungen zur transdermalen absorption
DE29705272U1 (de) Putztapete
DK0879051T3 (da) Hastighedskontrolleret transdermal indgivelse af risperidon
DK0906127T3 (da) Nye instrumenter til transdermal indgivelse af trimegeston
ATE280575T1 (de) Transdermales therapeutisches system zur anwendung von candesartan
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
FI913645A0 (fi) Transdermalt system med vilket farmakologiskt aktiva foereningar appliseras i effekt-kontrollerade faorhaollanden.